Last reviewed · How we verify
NCT06206122
Effect of Intermittent Oro-esophageal Tube Feeding on Dysphagic Patients With Parkinson Disease
NA trial testing Nasogastric tube in Parkinson Disease. Withdrawn.
1 April 2024
Quick facts
| Lead sponsor | Zeng Changhao |
|---|---|
| Phase | NA |
| Status | Withdrawn |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Start date | 5 January 2024 |
| Primary completion | 1 April 2024 |
| Estimated completion | 5 April 2024 |
| Sites | 1 location across China |
Drugs / interventions tested
- Nasogastric tube
- Intermittent Oro-esophageal Tube
- Comprehensive rehabilitation training
Conditions studied
- Parkinson Disease — all drugs for Parkinson Disease →
Sponsor
Zeng Changhao — full company profile →
Who can join
18 and older, any sex, with Parkinson Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this or clinical trial is to explore Intermittent Oro-esophageal Tube Feeding vs. Nasogastric Tube Feeding on nutritional status, dysphagia, and activities of daily living in patients with Parkinson's disease. The main question it aims to answer are: • Can stellate ganglion block improve the nutritional status, dysphagia, and activities of daily living in patients with Parkinson's disease, better than Nasogastric Tube Feeding. Participants will be divided into the control group and observation group evenly. All the patients were provided with routine therapy and given nutritional support by Intermittent Oro-esophageal Tube Feeding and Nasogastric Tube Feeding respectively. The nutritional status, swallowing function, and activities of daily living of the two groups of patients before and after treatment were evaluated.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06206122
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Nasogastric tube
Trials testing the same drug.
- NCT06220292 — Intermittent Oral-esophageal Tube Feeding in Alzheimer's Patients With Dysphagia · NA · withdrawn
- NCT06179550 — Intermittent Oro-esophageal Tube Feeding on Cerebral Small Vessel Disease Patients With Dysphagia · NA · terminated
- NCT06303999 — Effect of Oral Enteral Nutrition on Cerebral Small Vessel Disease · NA · completed
Other recruiting trials for Parkinson Disease
Currently open trials in the same condition.
- NCT07399496 — Accelerated TMS for Apathy in PD · NA · recruiting
- NCT07371338 — Phase 1 Clinical Trial to Evaluate the Safety, Efficacy, and Pharmacokinetics of IPS101A in Parkinson's Disease Patients · Phase 1 · recruiting
- NCT07442370 — The Effect of Functional Rotational Exercises on Fall Risk and Mobility in Parkinson's Disease Patients · NA · recruiting
- NCT06848205 — Percept Transitions in FOG and PD · NA · recruiting
- NCT07432958 — A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (P · Phase 2 · recruiting
Other Zeng Changhao trials
Trials by the same sponsor.
- NCT06265792 — Efficacy of Stellate Ganglion Block in Obstructive Sleep Apnea · NA · unknown
- NCT06265844 — Multifunctional Nutrition Tube in Dysphagia for Nasopharyngeal Carcinoma · NA · unknown
- NCT06265779 — Transcranial Direct Current Stimulation Combined With Intermittent Oral to Esophageal Tube on Dysphagia · NA · unknown
- NCT06255353 — Effect of Different Feeding Modes in Intracerebral Hemorrhage · NA · completed
- NCT06265805 — Effect of Different Feeding Modes on Psychological Condition and Experience in Stroke Patients · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06206122 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Zeng Changhao
- Last refreshed: 5 March 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06206122.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing